According to the latest data from the Hong Kong Stock Exchange, Orient Securities sold 160,000 shares of REMEGEN on May 19 at an average price of HK$84.8306 per share, totaling approximately HK$13.57 million. Following this reduction, the firm's shareholding now stands at 10.3745 million shares, representing a 4.97% stake.